Stallergenes Greer

Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies. It is known for its innovative approaches in developing, manufacturing, and distributing allergen immunotherapy products. Allergen immunotherapy is a treatment aimed at decreasing sensitivity to allergens, potentially leading to long-term relief from allergic symptoms.

History

Stallergenes Greer was formed through the merger of two pioneering companies in the field of allergen immunotherapy: Stallergenes, established in France, and Greer Laboratories, based in the United States. This merger combined Stallergenes' expertise in sublingual immunotherapy treatments with Greer Laboratories' focus on subcutaneous immunotherapy products, creating a comprehensive portfolio of allergy solutions.

Products and Services

The company offers a wide range of products and services for the diagnosis and treatment of allergic diseases. These include:

• Sublingual Immunotherapy Tablets (SLIT-tablets): These are orally administered tablets for specific allergies, such as grass pollen, house dust mites, and ragweed.
• Subcutaneous Immunotherapy (SCIT): This traditional form of allergy shots is administered under the skin and is tailored to the individual's allergic profile.
• Diagnostic Tools: Stallergenes Greer provides a variety of diagnostic tools to accurately identify allergens responsible for patients' symptoms, facilitating targeted treatment plans.

Research and Development

Stallergenes Greer is committed to advancing the field of allergology through ongoing research and development efforts. The company invests in clinical trials to explore new therapeutic avenues and improve existing treatments. Their focus on innovation aims to enhance the efficacy, safety, and patient experience of allergen immunotherapy.

Global Presence

With operations in Europe, North America, and other parts of the world, Stallergenes Greer has a significant international footprint. The company's global reach allows it to make a meaningful impact on the lives of patients with allergies worldwide.

Challenges and Opportunities

The field of allergen immunotherapy faces several challenges, including the need for personalized treatment approaches and the improvement of patient adherence to long-term therapy. However, Stallergenes Greer views these challenges as opportunities to further innovate and refine their offerings, with the ultimate goal of improving patient outcomes in allergic diseases.

Conclusion

Stallergenes Greer plays a crucial role in the field of allergology, offering a broad spectrum of products and services for the diagnosis and treatment of allergies. Through its commitment to research and development, the company continues to push the boundaries of what is possible in allergen immunotherapy, striving to provide better health and quality of life for patients around the globe.